Global reduction of hib disease: What are the next steps? Proceedings of the meeting, Scottsdale, Arizona, September 22-25, 2002

Journal of Pediatrics

Volumn 143, Issue 6 SUPPL., 2003, Pages 163-187

  Watt, James P ^a   Levine, Orin S ^a   Santosham, Mathuram ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE CRM197 CONJUGATE VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE DIPHTHERIA TOXOID VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE OUTER MEMBRANE CONJUGATE VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE TETANUS TOXOID CONJUGATE VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE;

BACTERIAL INFECTION; CHILE; CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPING COUNTRY; DIABETES MELLITUS; DRUG EFFICACY; DRUG FEVER; DRUG FORMULATION; DRUG SAFETY; EPIDEMIOLOGICAL DATA; GAMBIA; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; IMMUNE RESPONSE; IMMUNITY; INCIDENCE; INDUSTRIALIZATION; INFECTION CONTROL; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES; VACCINATION; VACCINATION REACTION; WORLD HEALTH ORGANIZATION;

EID: 0345527005     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/s0022-3476(03)00576-6     Document Type: Conference Paper

References (84)

1. Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. Health Econ 2000;9:19-35.
2. Moxon ER, Kroll JS. Type b capsular polysaccharide as a virulence factor of Haemophilus influenzae. Vaccine 1988;6:113-5.
3. Kroll JS, Moxon ER. Capsulation in distantly related strains of Haemophilus influenzae type b: genetic drift and gene transfer at the capsulation locus. J Bacteriol 1990;172:1374-9.
4. Zwahlen A, Kroll JS, Rubin LG, Moxon ER. The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap. Microb Pathog 1989;7:225-35.
5. Moxon ER, Vaughn KA. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J Infect Dis 1981;143:517-24.
6. Kroll JS, Moxon ER, Loynds BM. An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b. J Infect Dis 1993;168:172-6.
7. Musser JM, Kroll JS, Moxon ER, Selander RK. Evolutionary genetics of the encapsulated strains of Haemophilus influenzae. Proc Natl Acad Sci U S A 1988;85:7758-62.
8. Peltola H, Kayhty H, Sivonen A, et al. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60:730-7.
9. Peltola H, Käyhty H, Virtanen M, Mäkelä PH. Prevention of Haemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med 1984;310:1561-6.
10. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7.
11. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996;15:216-22.
12. Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol Rev 1999;21:43-55.
13. Vuori-Holopainen E, Peltola H. Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia [review]. Clin Infect Dis 2001;32:715-26.
14. Ward J, Zangwill K. Haemophilus influenzae vaccines. In: Plotkin S, Orenstein W, editors. Vaccines. 3rd edition. Philadelphia (PA): WB Saunders; 1999. p. 183-221.
15. Takala AK, Eskola J, Peltola H, Makela PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989;8:297-302.
16. Bijlmer HA, van Alphen L, Greenwood BM, Brown J, Schneider G, Hughes A, et al. The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis 1990;161:1210-5.
17. Bryan JP, Rodriques de Silva H, Tavares A, Rocha H, Scheld WM. Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis 1990;12:128-35.
18. Kilpatrick ME, Mikhail IA, Girgis NI. Negative cultures of cerebrospinal fluid in partially treated bacterial meningitis. Trop Geograph Med 1987;39:345-9.
19. Shann F. The management of pneumonia in children in developing countries. Clin Infect Dis 1995;21(Suppl 3):S218-S225.
20. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-52.
21. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998;17:S117-S122.
22. Santosham M, Reid R, Ambrosino DM, Wolff MC, Almeido-Hill J, Priehs C, et al. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med 1987;317:923-9.
23. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992;120:184-9.
24. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Pediatr Infect Dis J 1993;12:484-92.
25. Ward J, Brenneman G, Letson GW, Heyward WL. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants: the Alaska H influenzae Vaccine Study Group. N EnglJ Med 1990;323:1393-401.
26. Takala AK, Eskola J, Leinonen M, Kayhty H, Nissinen A, Pekkanen E, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
27. Takala AK, Santosham M, Almeido-Hill J, Wolff M, Newcomer W, Reid R, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12:593-9.
28. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus influenzae colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine J Pediatr 1993;122:517-23.
29. Barbour ML. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1996;2:93-8.
30. Heath PT, Bowen-Morris J, Griffiths D, Griffiths H, Crook DW, Moxon ER. Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T. Arch Dis Child 1997;77:488-92.
31. Adegbola RA, Mulholland EK, Secka O, Jaffar S, Greenwood BM. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H influenzae type b among Gambian children. J Infect Dis 1998;177:1758-61.
32. Peltola H. Haemophilus influenzae type b disease and vaccination in Europe: lessons learned. Pediatr Infect Dis J 1998;17:S126-S132.
33. Kauppi M, Eskola J, Kayhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J 1995;14:286-94.
34. Black SB, Lewis E, Shinefield HR, Fireman B, Ray P, DeStefano F, et al. Lack of association between receipt of conjugate Haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. Pediatr Infect Dis J 2002;6:568-9.
35. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus- pertussis containing acellular pertussis. Lancet 1999;354:2063-8.
36. Barker L, Luman E, MS, Zhao Z, Smith P, Linkins R, Santoli J, et al. National, state, and urban area vaccination coverage levels among children aged 19-35 months: United States, 2001. MMWR Morb Mortal Wkly Rep 2002;51:664-6.
37. Centers for Disease Control and Prevention. Serotyping discrepancies in Haemophilus Influenzae type b disease. MMWR Morb Mortal Wkly Rep 2002;51:706-7.
38. LaClaire L, Tondella L, Beall ML, Noble DS, Raghunathan CA, Rosenstein PL, et al. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol 2003;41:393-6.
39. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine: a cost-effectiveness model of strategy assessment. JAMA 1985;253:521-9.
40. Bath S, Bisgard K, Murphy T, Shutt K, Rosenstein N, Ohuabunwo C. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children: United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002;51:234-7.
41. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the USA. Pediatr Infect Dis J 1987;6:779-82.
42. Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Hemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998;4:229-37.
43. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998;17:S132-6.
44. Losonsky GA, Santosham M, Sehgal VM, Zwahlen A, Moxon ER. Haemophilus influenzae disease in the White Mountain Apaches: molecular epidemiology of a high-risk population. Pediatr Infect Dis 1984;3:539-47.
45. Yost GC, Kaplan AM, Bustamante R, Ellison C, Hargrave AF III, Randall DL. Bacterial meningitis in Arizona American Indian children. Am J Dis Child 1986;140:943-6.
46. Coulehan JL, Michaels RH, Hallowell C, Schults R, Welty TK, Kuo JS. Epidemiology of Haemophilus influenzae type B disease among Navajo Indians. Public Health Rep 1984;99:404-9.
47. Millar EV, O'Brien KL, Levine OS, Kvamme S, Reid R, Santosham M. Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. Am J Public Health 2000;90:1550-4.
48. Singleton R, Bulkow LR, Levine OS, Butler JC, Hennessy TW, Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. J Pediatr 2000;137:313-20.
49. Galil K, Singleton RJ, Levine OS, Fitzgerald MA, Bulkow L, Getty M, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101-6.
50. Kauppi M, Saarinen L, Kayhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J Infect Dis 1993;167:365-71.
51. Fernandez J, Levine OS, Sanchez J, Balter S, LaClair L, Feris J, et al. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. JID 2000;182:1553-6.
52. Perdue DG, Bulkow LR, Gellin BG, Davidson M, Petersen KM, Singleton RJ, et al. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA 2000;283:3089-94.
53. Hargreaves RM, Slack MP, Howard AJ, et al. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996;312:160-1.
54. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-9.
55. Gilbert GL. Epidemiology of Haemophilus influenzae type b disease in Australia and New Zealand. Vaccine 1991;9:S10-3.
56. McIntyre P. Worldwide epidemiology of invasive Hib disease. JAMA (SE Asia) 1993;9:5-10.
57. Guthridge S, McIntyre P, Isaacs D, Hanlon M, Patel M. Differing serologic responses to an Haemophilus influenzae type b polysaccharide- neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian aboriginal and Caucasian infants: implications for disease epidemiology. Vaccine 2000;18:2584-91.
58. Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. Health Econ 2000,9:19-35.
59. Levine OS, Lagos R, Munoz A, Villaroel J, Alvarez AM, Abrego P, et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999;18:1060-4.
60. Adegbola RA, Usen SO, Weber M, Lloyd-Evans N, Jobe K, Mullholland KPWJ, et al. Hemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet 1999;354:1091-2.
61. Levine OS, Liu G, Garman RL, Dowell SF, Yu S, Yang YH. Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia among children in Beijing, China. Emerg Infect Dis 2000;6:165-70.
62. Bijlmer HA, van Alphen L. A prospective, population-based study of Haemophilus influenzae type b meningitis in The Gambia and the possible consequences [review]. J Infect Dis 1992;165(Suppl 1):S29-32.
63. Biljmer HA. World-wide epidemiology of Haemophilus influenzae meningitis: industrialized versus non-industrialized countries. Vaccine 1991;9:5-9.
64. Goetghebuer T, West TE, Wermenbol V, Cadbury AL, Milligan P, Lloyd-Evans N, et al. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop Med Int Health 2000;5:207-13.
65. Levine OS, Schwartz B. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis. Pediatr Infect Dis J 1998;17(Suppl 9):S195-8.
66. Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000;31:170-6.
67. Madhi SA, Madhi A, Petersen K, Khoosal M, Klugman KP. Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis 2001;5:119-25.
68. Madhi SA, Petersen K, Khoosal M, Huebner RE, Mbelle N, Mothupi R, et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 2002;21:315-21.
69. Gessner BD. Worldwide variation in the incidence of Haemophilus influenzae type b meningitis and its association with ampicillin resistance. Eur J Clin Microbiol Infect Dis 2002;21:79-87.
70. Lolekha S, Cooksley G, Chan V, Isahak I, Ismael S, John J, et al. A review of Hib epidemiology in Asia [review]. Southeast Asian J Trop Med Public Health 2000;31:650-7.
71. Lau YL, Yung R, Low L, Sung R, Leung C, Lee WH. Haemophilus influenzae type b infections in Hong Kong. Pediatr Infect Dis J 1998;17:S165-9.
72. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections [review]. Lancet Infect Dis 2002;2:25-32.
73. Wang YJ, Vuori-Holopainen E, Yang Y, Wang Y, Hu Y, Leboulleux D, et al. Relative frequency of Haemophilus influenzae type b pneumonia in Chinese children as evidenced by serology. Pediatr Infect Dis J 2002;4:271-7.
74. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children [review]. J Infect Dis 1992;165(Suppl 1):S20-5.
75. Yang Y, Shen X, Vuori-Holopainen E, Leboulleux D, Wang YJ, Leinonen M, et al. Seroetiology of acute lower respiratory infections among hospitalized children in Beijing. Pediatr Infect Dis J 2001;20:52-8.
76. Levine OS, Liu G, Garman RL, Dowell SF, Yu S, Yang YH. Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia among children in Beijing, China. Emerg Infect Dis 2000;6:165-70.
77. Chotpitayasunondh T. Haemophilus influenzae type b disease in Thailand. Pediatr Infect Dis J 1998;17(Suppl 9):S191.
78. Steinhoff MC. Invasive Haemophilus influenzae disease in India: a preliminary report of prospective multihospital surveillance. IBIS (Invasive Bacterial Infections Surveillance) Group. Pediatr Infect Dis J 1998;17:172-5.
79. Baqui AH, Black RE, Arifeen SE, Hill K, Mitra SN, al Sabir A. Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study. Bull World Health Org 1998;76:161-71.
80. Saha SK, Rikitomi N, Ruhulamin M, Watanabe K, Ahmed K, Biswas D, et al. The increasing burden of disease in Bangladeshi children due to Haemophilus influenzae type b meningitis. Ann Trop Paediatr 1997;17:5-8.
81. Nicol M. Pediatr Infect Dis J 2002;21:138-41.
82. Fernandez J, Baiter S, Feris J, Gomez E, Garib Z, Castellanos PL, et al. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 2000;62:485-90.
83. Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, et al. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol 2001;8:1115-9.
84. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, et al. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998;351:1472-6.